Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding
Wai Hoong Chang(University College London), Alvina G. Lai(Health Data Research UK), Yen Yi Tan(National University of Singapore), Stefanie H. Mueller(Christian-Albrechts-Universität zu Kiel)
Cited by 23
Related Papers
Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England
|The Lancet Healthy Longevity|2022|280
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease
|Movement Disorders|2020|59
Late effects of cancer in children, teenagers and young adults: Population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost
|The Lancet Regional Health - Europe|2021|50
Organ System Network Disruption Is Associated With Poor Prognosis in Patients With Chronic Liver Failure
|Frontiers in Physiology|2020|25